NIH-funded research P30 center grant

Investigating gene editing techniques for eye diseases

Official title: Viral Production and CRISPR Engineering

Funded at University of California, San Diego · NIH-11092250 · Data updated 2026-11-12

This study is working on new ways to use viruses to help fix genes that cause vision problems, like age-related macular degeneration, with the hope of finding better treatments for people who have trouble seeing.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$83,857
NIH project number5P30EY022589-13
Project IDNIH-11092250 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with age-related macular degeneration or other inherited retinal degenerations.

Less likely to help

Patients with non-genetic forms of vision impairment or those not affected by the targeted eye diseases may not benefit from this research.

What this research studies

This research focuses on developing advanced viral vectors to deliver gene editing tools, specifically targeting conditions like age-related macular degeneration. By utilizing adeno-associated viruses (AAV) and lentiviruses, the team aims to create conditions that either activate or inhibit specific genes involved in eye diseases. The approach includes using CRISPR technology to modify genes in rodent models, which could lead to new treatments for patients with vision impairments. The research also explores the potential of these vectors to express therapeutic genes directly.

Why it matters

Potential benefit: If successful, this research could lead to innovative gene therapies that improve or restore vision in patients suffering from age-related macular degeneration and other eye diseases.

How similar studies have gone: Previous research has shown promising results using similar gene editing approaches in other conditions, indicating potential for success in this area as well.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Welsbie, Derek Stuart — University of California, San Diego
  • Study coordinator: Welsbie, Derek Stuart

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.